Literature DB >> 25986527

Associations Between Parameters of Glucose and Lipid Metabolism and Risk of Colorectal Neoplasm.

Yoon Suk Jung1, Seungho Ryu2,3, Yoosoo Chang2,3, Kyung Eun Yun3, Jung Ho Park1, Hong Joo Kim1, Yong Kyun Cho1, Chong Il Sohn1, Woo Kyu Jeon1, Byung Ik Kim1, Kyuyong Choi1, Dong Il Park4.   

Abstract

BACKGROUND: Diabetes and dyslipidemia have been linked to an increased risk of colorectal neoplasm (CRN). However, previous studies evaluating these associations have shown inconsistent results, and large-scale studies are few in number. AIM: To investigate the associations between the parameters of glucose and lipid metabolism and the presence of CRN.
METHODS: A cross-sectional study was performed on 38,490 Korean adults aged ≥30 years undergoing their first colonoscopy as part of routine preventive health care between 2010 and 2011.
RESULTS: The prevalence of overall CRN increased with increasing levels of glucose, hemoglobin A1c (HbA1c), insulin, homeostasis model assessment of insulin resistance (HOMA-IR), triglycerides, total cholesterol, low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B (ApoB) and with decreasing level of apolipoprotein A1 (ApoA1). The adjusted prevalence ratios for overall CRN comparing the fourth with the first quartiles of fasting glucose, HbA1c, insulin, HOMA-IR, triglycerides, total cholesterol, LDL-C, ApoB, and ApoA-1 were 1.83 (95% CI 1.62-2.06), 1.17 (95% CI 1.03-1.33), 1.09 (95% CI 0.97-1.23), 1.22 (95% CI 1.08-1.37), 1.31 (95% CI 1.16-1.48), 1.19 (95 % CI 1.07-1.33), 1.38 (95% CI 1.23-1.54), 1.30 (95% CI 1.14-1.47), and 0.85 (95% CI 0.76-0.95), respectively. There was also a significant association between higher levels of glucose, LDL-C, and ApoB with a higher prevalence of advanced CRN. Moreover, the risk of CRN increased further in cases in which the parameters of glucose metabolism and lipid metabolism worsened simultaneously.
CONCLUSIONS: The levels of parameters of glucose and lipid metabolism are significantly associated with the prevalence of CRN. Altered glucose and lipid metabolism may contribute to the development of CRN.

Entities:  

Keywords:  Colorectal neoplasia; Dyslipidemia; Glucose metabolism; Risk factors

Mesh:

Substances:

Year:  2015        PMID: 25986527     DOI: 10.1007/s10620-015-3713-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  39 in total

1.  Serum triglycerides and colorectal adenoma in a case-control study among cancer screening examinees (Japan).

Authors:  Tetsuya Otani; Motoki Iwasaki; Shinobu Ikeda; Takahiro Kozu; Hiroshi Saito; Michihiro Mutoh; Keiji Wakabayashi; Shoichiro Tsugane
Journal:  Cancer Causes Control       Date:  2006-12       Impact factor: 2.506

2.  Association between markers of glucose metabolism and risk of colorectal adenoma.

Authors:  Sanjay Rampal; Moon Hee Yang; Jidong Sung; Hee Jung Son; Yoon-Ho Choi; Jun Haeng Lee; Young-Ho Kim; Dong Kyung Chang; Poong-Lyul Rhee; Jong Chul Rhee; Eliseo Guallar; Juhee Cho
Journal:  Gastroenterology       Date:  2014-03-14       Impact factor: 22.682

3.  Clinical usefulness of glycosylated hemoglobin as a predictor of adenomatous polyps in the colorectum of middle-aged males.

Authors:  Beom Jin Kim; Young-Ho Kim; Dong Hyun Sinn; Ki Joo Kang; Jin Yong Kim; Dong Kyung Chang; Hee Jung Son; Poong-Lyul Rhee; Jae J Kim; Jong Chul Rhee
Journal:  Cancer Causes Control       Date:  2010-04-07       Impact factor: 2.506

4.  Association of colorectal adenoma with components of metabolic syndrome.

Authors:  Byung Chang Kim; Aesun Shin; Chang Won Hong; Dae Kyung Sohn; Kyung Su Han; Kum Hei Ryu; Bum Joon Park; Ji Hyung Nam; Ji Won Park; Hee Jin Chang; Hyo Seong Choi; Jeongseon Kim; Jae Hwan Oh
Journal:  Cancer Causes Control       Date:  2012-03-27       Impact factor: 2.506

Review 5.  Dyslipidemia and inflammation: an evolutionary conserved mechanism.

Authors:  Eduardo Esteve; Wifredo Ricart; José Manuel Fernández-Real
Journal:  Clin Nutr       Date:  2005-02       Impact factor: 7.324

6.  Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population.

Authors:  Ya-Yu Wang; Shih-Yi Lin; Wen-An Lai; Pi-Hwa Liu; Wayne Huey-Herng Sheu
Journal:  J Gastroenterol Hepatol       Date:  2005-09       Impact factor: 4.029

7.  Metabolic syndrome components and colorectal adenoma in the CLUE II cohort.

Authors:  Konstantinos K Tsilidis; Frederick L Brancati; Michael N Pollak; Nader Rifai; Sandra L Clipp; Judith Hoffman-Bolton; Kathy J Helzlsouer; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2009-09-23       Impact factor: 2.506

8.  Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ.

Authors:  K Yamada; S Araki; M Tamura; I Sakai; Y Takahashi; H Kashihara; S Kono
Journal:  Int J Epidemiol       Date:  1998-10       Impact factor: 7.196

9.  Association of markers of insulin and glucose control with subsequent colorectal cancer risk.

Authors:  Sharon H Saydah; Elizabeth A Platz; Nader Rifai; Michael N Pollak; Frederick L Brancati; Kathy J Helzlsouer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-05       Impact factor: 4.254

Review 10.  Clinical application of genetics in management of colorectal cancer.

Authors:  Eun Ran Kim; Young-Ho Kim
Journal:  Intest Res       Date:  2014-07-25
View more
  4 in total

1.  Parameters of Glucose and Lipid Metabolism Affect the Occurrence of Colorectal Adenomas Detected by Surveillance Colonoscopies.

Authors:  Nam Hee Kim; Jung Yul Suh; Jung Ho Park; Dong Il Park; Yong Kyun Cho; Chong Il Sohn; Kyuyong Choi; Yoon Suk Jung
Journal:  Yonsei Med J       Date:  2017-03       Impact factor: 2.759

2.  Serum Apolipoprotein A-I Combined With C-Reactive Protein Serves As A Novel Prognostic Stratification System For Colorectal Cancer.

Authors:  Juan Ye; Qiu-Yun Luo; Xue-Ping Wang; Zhen-Yi Liu; Mei-Xian Chen; Hao Huang; Lin Zhang
Journal:  Cancer Manag Res       Date:  2019-10-30       Impact factor: 3.989

3.  The Prognostic Value of Serum Apolipoprotein A-I Level and Neutrophil-to-Lymphocyte Ratio in Colorectal Cancer Liver Metastasis.

Authors:  Chongkai Fang; Yue Huang; Chuyao Chen; Duorui Nie; Jietao Lin; Zhiwei Xiao; Saimei Li; Silin Liu; Rui Luo; Hongtong Lin; Chong Zhong; Xuewu Huang; Cui Shao
Journal:  J Oncol       Date:  2022-09-27       Impact factor: 4.501

4.  Statins Dose-Dependently Exert Significant Chemopreventive Effects Against Various Cancers in Chronic Obstructive Pulmonary Disease Patients: A Population-Based Cohort Study.

Authors:  Chun-Chao Chen; Yi-Ping Hsu; Ju-Chi Liu; Pai-Feng Kao; Li-Chin Sung; Chao-Feng Lin; Wen-Rui Hao; Shing-Hwa Liu; Szu-Yuan Wu
Journal:  J Cancer       Date:  2016-09-13       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.